Gillian C Watson (Gillian Watson)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Urinary Tract Infection

Hodgkin Lymphoma

Top Venues

Health technology assessment (Winchester, England)

The Journal of clinical endocrinology and metabolism

BMJ (Clinical research ed.)

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Harding, Thomas Chadwick, Tara Homer, Jan Lecouturier, Helen Mossop, Sonya Carnell, William King, Alaa Abouhajar, Luke Vale, Gillian C Watson, Rebecca Forbes, Stephanie Currer, Robert Pickard, Ian Eardley, Ian Pearce, Nikesh Thiruchelvam, Karen L Guerrero, Katherine Walton, Zahid Hussain, Henry Lazarowicz, Ased Ali
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health technology assessment (Winchester, England) 26 (23) (2022)
Tim Cheetham, Michael Cole, Mario Abinun, Amit Allahabadia, Tim Barratt, Justin Huw Davies, Paul Dimitri, Amanda Jane Drake, Zainaba Mohamed, Robert D Murray, Caroline Steele, Nicola Zammitt, Sonya Carnell, Jonathan Prichard, Gillian C Watson, Sophie Hambleton, John N S Matthews, Simon H S Pearce
Adjuvant Rituximab - exploratory trial in young people with Graves' disease. The Journal of clinical endocrinology and metabolism (2021)
Janet A Wilson, Deborah D Stocken, Gillian C Watson, Tony Fouweather, Julian McGlashan, Kenneth MacKenzie, Paul N Carding, Yakubu Karagama, Meredydd Harries, Stephen Ball, Sadie Khawaja, Declan Costello, Ruth C Wood, Jan Lecouturier, James O'Hara
Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT. Health technology assessment (Winchester, England) 25 (3) (2021)
James O'Hara, Deborah D Stocken, Gillian C Watson, Tony Fouweather, Julian McGlashan, Kenneth MacKenzie, Paul Carding, Yakubu Karagama, Ruth C Wood, Janet A Wilson
Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial. BMJ (Clinical research ed.) 372 (2021)